| Company Name: |
Chemsky（shanghai）International Co.,Ltd.
|
| Tel: |
021-50135380 |
| Email: |
shchemsky@sina.com |
| Products Intro: |
Product Name:(2S,4S)-FMoc-4-cyclohexyl-pyrrolidine-2-carboxylic acid
CAS:467438-40-0
Purity:98%+ Package:2000RMB/100MG; 3400RMB/250MG; 5500RMB/1G
|
| Company Name: |
Shanghai GL Peptide Ltd.
|
| Tel: |
+86-21-61263310; 13764994101 13764994101 |
| Email: |
fisherwang@glschina.com |
| Products Intro: |
Product Name:(2S,4S)-Fmoc-4-cyclohexyl-pyrrolidine-2-carboxylic acid
CAS:467438-40-0
Purity:95%，98% Package:1g,5g,10g,25g,50g,100g,500g,1kg
|
| Company Name: |
Wuxi Asia Peptide Biotechnology Limited Company
|
| Tel: |
0510-83583050 13771062561 |
| Email: |
willsun@peptide-search.com |
| Products Intro: |
Product Name:(2S,4S)-Fmoc-4-cyclohexyl-pyrrolidine-2-carboxylic acid
CAS:467438-40-0
Purity:98% HPLC Package:100g，500g
|
|
| | (2S,4S)-FMOC-4-CYCLOHEXYL-PYRROLIDINE-2-CARBOXYLIC ACID Basic information |
| Product Name: | (2S,4S)-FMOC-4-CYCLOHEXYL-PYRROLIDINE-2-CARBOXYLIC ACID | | Synonyms: | (2S,4S)-FMOC-4-CYCLOHEXYL-PYRROLIDINE-2-CARBOXYLIC ACID;(2S,4S)-Fmoc-4-cyclohexyl-Pro-OH;1,2-Pyrrolidinedicarboxylic acid, 4-cyclohexyl-, 1-(9H-fluoren-9-ylmethyl) ester, (2S,4S)-;(2S,4S)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-4-cyclohexylpyrrolidine-2-carboxylic acid;(2S,4S)-1-(9H-Fluoren-9-ylmethyl) Ester 4-Cyclohexyl-1,2-pyrrolidinedicarboxylic Acid;(2S,4S)-4-cyclohexyl-1-{[(9H-fluoren-9-yl)methoxy]carbonyl}pyrrolidine-2-carboxylic acid;N-Fmoc-(4S)-4-cyclohexyl-L-proline | | CAS: | 467438-40-0 | | MF: | C26H29NO4 | | MW: | 419.51 | | EINECS: | | | Product Categories: | | | Mol File: | 467438-40-0.mol |  |
| | (2S,4S)-FMOC-4-CYCLOHEXYL-PYRROLIDINE-2-CARBOXYLIC ACID Chemical Properties |
| Boiling point | 608.7±48.0 °C(Predicted) | | density | 1?+-.0.06 g/cm3(Predicted) | | pka | 3.95±0.40(Predicted) |
| | (2S,4S)-FMOC-4-CYCLOHEXYL-PYRROLIDINE-2-CARBOXYLIC ACID Usage And Synthesis |
| Uses | (2S,4S)-1-(9H-Fluoren-9-ylmethyl) Ester 4-Cyclohexyl-1,2-pyrrolidinedicarboxylic Acid is used in preparation of Macrocyclic Peptides as inhibitors of PD-1/PD-L1 and CD80/PD-L1 protein/protein interactions for treating cancers and infections. |
| | (2S,4S)-FMOC-4-CYCLOHEXYL-PYRROLIDINE-2-CARBOXYLIC ACID Preparation Products And Raw materials |
|